注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Pear Therapeutics Inc(原名:Thimble Point Acquisition Corp)是一家商业阶段的医疗保健公司。该公司致力于开发一类新的基于软件的药物,称为处方数字疗法(PDT),它使用软件来治疗疾病。该公司的产品包括重置产品、reSET-O和Somryst。该公司的重置产品适用于作为单一疗法治疗物质使用障碍(SUD)。reSET-O产品开发用于与丁丙诺啡联合治疗阿片类药物使用障碍(OUD)。Somryst产品是唯一基于软件和指南推荐的慢性失眠治疗方法。该公司的产品线包括14个候选产品,包括精神病学、神经病学和中枢神经系统治疗领域以外的候选产品,如胃肠(GI)、肿瘤学和心血管。该公司专注于精神疾病和神经系统疾病,这支持其将自己的产品商业化的战略。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Elon S. Boms | 40 | - | CEO & Chairman of the Board |
Steven J. Benson | 62 | - | COO & Director |
Henry S. Miller | 75 | 2021 | Independent Director |
Michael J. Christenson | 62 | 2021 | Independent Director |
Meghan M. FitzGerald | 50 | 2021 | Independent Director |
Corey M. McCann | 43 | 2013 | Founder & Director |
Alex Paul Pentland | 72 | - | Member of Scientific Advisory Board |
Harold S. Koplewicz | 71 | - | Member of Scientific Advisory Board |
Magali Haas | - | - | Member of Scientific Advisory Board |
Eric C. Leuthardt | - | - | Member of Scientific Advisory Board |
Walter Greenleaf | - | - | Member of Scientific Advisory Board |
Joann Difede | - | - | Member of Scientific Advisory Board |
Patrick J. Kennedy | - | - | Member of Scientific Advisory Board |
Paul Summergrad | - | - | Member of Scientific Advisory Board |
Albert A. Rizzo | - | - | Member of Scientific Advisory Board |
Jeffrey A. Lieberman | - | - | Member of Scientific Advisory Board |
Lisa A. Marsch | - | - | Member of Scientific Advisory Board |
Alison Perry Bauerlein | 43 | 2021 | Independent Director |
Shivakumar Rajaraman | 50 | 2022 | Independent Director |
Paul Mango | - | 2022 | Independent Director |
Timothy A. Wicks | 58 | 2022 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核